Entity Wide Disclosures (Tables)

3 Months Ended

Mar. 31, 2021

Entity Wide Disclosures [Abstract]

Summary of Revenue by Major Source

The following table disaggregates our revenue by major source (in thousands):

	Three Months Ended March 31, 2021		Three Months Ended March 31, 2020
Therapeutic Area
Oncology	$	79,138	$	69,212
Other		68,938		50,569
Metabolic		32,495		36,075
AVAI		30,820		25,147
Central Nervous System		24,812		23,977
Cardiology		23,762		25,899
Total revenue	$	259,965	$	230,879